BioCatalystWatch
BNTCWorkspace / BNTC / OverviewCompany library
Benitec Biopharma Inc. logo

Benitec Biopharma Inc.

Benitec Biopharma Inc. (BNTC)

Website

Price
Market cap
Next catalystPivotal-trial initiation planned for mid-2027BB-301 — planned open-label, single-arm pivotal study · Trial initiationCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

BB-301

Mutant PABPN1

Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

BB-301

Mutant PABPN1

Upcoming / outlook

  • Timing and evidence

Other pipelines

BB-301

Mutant PABPN1

PreINDP1P2P3FilingApproved

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BNTC PR & News

PR & News

BNTC SEC archive